Actavis 4Q Revenues: $4.1 billion (+46%) 4Q Loss: $732.9 million (loss of $148.4 million 4Q13) FY Revenues: $13.1 billion (+51%) FY Loss: $1.6 billion (loss of $750.4 million FY13) Comments: North American Brands business revenues were $1.8 billion, up 188%, primarily driven by the acquisition of Forest, as well as double-digit growth for the Namenda franchise, Linzess, Estrace Cream, Teflaro, and Bystolic. North American Generics & International revenue was $1.8 billion, up 1%, with gr...